Enveric Biosciences Announces Patent Granted for Drug CandidateEnveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company dedicated to the development of novel neuroplastogens for the treatment of neuropsychiatric disorders, today...
Business Wire•17 days ago